Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema Diagnosed in the Preoperative Period via Bioimpedance

Objective: The aim of this study was to evaluate the relationship between subclinical lymphedema identified prior to surgical intervention and clinical lymphedema observed in the late period, the incidence of lymphedema in our cohort, and the associated risk factors. Materials and Methods: This pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Zeynep Erdoğan İyigün, Tolga Ozmen, Serkan İlgün, Cansu Nakipoğlu, Enver Özkurt, Filiz Çelebi, Çağlar Ünal, Alper Öztürk, Gül Alço, Çetin Ordu, Gürsel Soybir
Format: Article
Language:English
Published: Galenos Publishing House 2025-01-01
Series:European Journal of Breast Health
Subjects:
Online Access:https://www.eurjbreasthealth.com/articles/evaluation-of-long-term-lymphedema-rate-in-patients-with-subclinical-lymphedema-diagnosed-in-the-preoperative-period-via-bioimpedance/doi/ejbh.galenos.2024.2024-9-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556253341384704
author Zeynep Erdoğan İyigün
Tolga Ozmen
Serkan İlgün
Cansu Nakipoğlu
Enver Özkurt
Filiz Çelebi
Çağlar Ünal
Alper Öztürk
Gül Alço
Çetin Ordu
Gürsel Soybir
author_facet Zeynep Erdoğan İyigün
Tolga Ozmen
Serkan İlgün
Cansu Nakipoğlu
Enver Özkurt
Filiz Çelebi
Çağlar Ünal
Alper Öztürk
Gül Alço
Çetin Ordu
Gürsel Soybir
author_sort Zeynep Erdoğan İyigün
collection DOAJ
description Objective: The aim of this study was to evaluate the relationship between subclinical lymphedema identified prior to surgical intervention and clinical lymphedema observed in the late period, the incidence of lymphedema in our cohort, and the associated risk factors. Materials and Methods: This prospective study was conducted with early-stage breast cancer patients who had been enrolled in a previous study. For diagnosing lymphedema, physical examination, L-Dex® score, and circumferential measurement was used. The L-Dex® score was used as a screening test for preoperative, subclinical lymphedema since there were no clinical findings. Patients with subclinical lymphedema were provided with education and followed up more frequently with regular monitoring. Results: The mean age of the 217 participants was 56.7±12.7 years (range 29–90), and the mean body mass index was 27.7±3.3 kg/m2 (range 19.3–36.9). Among the 217 patients, lymphedema was detected in 31 (14.7%) at a median follow-up period of 89 months (range 73–108 months). Multivariable analysis of factors associated with late-stage lymphedema revealed positive lymph node count and capsular invasion as significant factors (p = 0.001 for both). Forty (18.4%) had preoperative subclinical lymphedema. At the end of the follow-up period, lymphedema persisted in 11 patients (27.5%) and resolved in 29 patients (72.5%). In multivariable analysis, the positive lymph node count was identified as an independent variable in these patients. Conclusion: Identifying high-risk patients, regular monitoring, and early intervention can significantly reduce the risk of clinical lymphedema through timely treatment.
format Article
id doaj-art-0049e5b922f64a8cb3048743f950a231
institution Kabale University
issn 2587-0831
language English
publishDate 2025-01-01
publisher Galenos Publishing House
record_format Article
series European Journal of Breast Health
spelling doaj-art-0049e5b922f64a8cb3048743f950a2312025-01-07T10:51:58ZengGalenos Publishing HouseEuropean Journal of Breast Health2587-08312025-01-01211404510.4274/ejbh.galenos.2024.2024-9-5Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema Diagnosed in the Preoperative Period via BioimpedanceZeynep Erdoğan İyigün0https://orcid.org/0000-0001-5353-1452Tolga Ozmen1https://orcid.org/0000-0002-7136-6195Serkan İlgün2https://orcid.org/0000-0002-4862-2891Cansu Nakipoğlu3https://orcid.org/0000-0003-2327-2271Enver Özkurt4https://orcid.org/0000-0003-2597-3119Filiz Çelebi5https://orcid.org/0000-0003-4020-4019Çağlar Ünal6https://orcid.org/0000-0003-3245-1570Alper Öztürk7https://orcid.org/0000-0002-7137-5374Gül Alço8https://orcid.org/0000-0002-3592-9923Çetin Ordu9https://orcid.org/0000-0003-4423-8005Gürsel Soybir10https://orcid.org/0000-0003-0626-0105Department of Physical Therapy and Rehabilitation, Bahçeşehir University Faculty of Medicine, İstanbul, TurkeyDivision of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, USACenter of Breast Health, İstanbul Florence Nightingale Hospital, İstanbul, TurkeyCenter of Breast Health, İstanbul Florence Nightingale Hospital, İstanbul, TurkeyCenter of Breast Health, İstanbul Florence Nightingale Hospital, İstanbul, TurkeyDeparment of Radiology, Yeditepe University Faculty of Medicine, İstanbul, TurkeyClinic of Oncology, University of Health Science Turkey İstanbul Kartal Lütfi Kırdar City Hospital, İstanbul, TurkeyDepartment of General Surgery, Biruni University Faculty of Medicine, İstanbul, TurkeyClinic of Radiation Oncology, Gayrettepe Florence Nightingale Hospital, İstanbul, TurkeyClinic of Medical Oncology, Gayrettepe Florence Nightingale Hospital, İstanbul, TurkeyClinic of General Surgery, Memorial Şişli Hospital, İstanbul, TurkeyObjective: The aim of this study was to evaluate the relationship between subclinical lymphedema identified prior to surgical intervention and clinical lymphedema observed in the late period, the incidence of lymphedema in our cohort, and the associated risk factors. Materials and Methods: This prospective study was conducted with early-stage breast cancer patients who had been enrolled in a previous study. For diagnosing lymphedema, physical examination, L-Dex® score, and circumferential measurement was used. The L-Dex® score was used as a screening test for preoperative, subclinical lymphedema since there were no clinical findings. Patients with subclinical lymphedema were provided with education and followed up more frequently with regular monitoring. Results: The mean age of the 217 participants was 56.7±12.7 years (range 29–90), and the mean body mass index was 27.7±3.3 kg/m2 (range 19.3–36.9). Among the 217 patients, lymphedema was detected in 31 (14.7%) at a median follow-up period of 89 months (range 73–108 months). Multivariable analysis of factors associated with late-stage lymphedema revealed positive lymph node count and capsular invasion as significant factors (p = 0.001 for both). Forty (18.4%) had preoperative subclinical lymphedema. At the end of the follow-up period, lymphedema persisted in 11 patients (27.5%) and resolved in 29 patients (72.5%). In multivariable analysis, the positive lymph node count was identified as an independent variable in these patients. Conclusion: Identifying high-risk patients, regular monitoring, and early intervention can significantly reduce the risk of clinical lymphedema through timely treatment.https://www.eurjbreasthealth.com/articles/evaluation-of-long-term-lymphedema-rate-in-patients-with-subclinical-lymphedema-diagnosed-in-the-preoperative-period-via-bioimpedance/doi/ejbh.galenos.2024.2024-9-5breast cancerlymphedemarisk factorsearly detection
spellingShingle Zeynep Erdoğan İyigün
Tolga Ozmen
Serkan İlgün
Cansu Nakipoğlu
Enver Özkurt
Filiz Çelebi
Çağlar Ünal
Alper Öztürk
Gül Alço
Çetin Ordu
Gürsel Soybir
Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema Diagnosed in the Preoperative Period via Bioimpedance
European Journal of Breast Health
breast cancer
lymphedema
risk factors
early detection
title Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema Diagnosed in the Preoperative Period via Bioimpedance
title_full Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema Diagnosed in the Preoperative Period via Bioimpedance
title_fullStr Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema Diagnosed in the Preoperative Period via Bioimpedance
title_full_unstemmed Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema Diagnosed in the Preoperative Period via Bioimpedance
title_short Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema Diagnosed in the Preoperative Period via Bioimpedance
title_sort evaluation of long term lymphedema rate in patients with subclinical lymphedema diagnosed in the preoperative period via bioimpedance
topic breast cancer
lymphedema
risk factors
early detection
url https://www.eurjbreasthealth.com/articles/evaluation-of-long-term-lymphedema-rate-in-patients-with-subclinical-lymphedema-diagnosed-in-the-preoperative-period-via-bioimpedance/doi/ejbh.galenos.2024.2024-9-5
work_keys_str_mv AT zeyneperdoganiyigun evaluationoflongtermlymphedemarateinpatientswithsubclinicallymphedemadiagnosedinthepreoperativeperiodviabioimpedance
AT tolgaozmen evaluationoflongtermlymphedemarateinpatientswithsubclinicallymphedemadiagnosedinthepreoperativeperiodviabioimpedance
AT serkanilgun evaluationoflongtermlymphedemarateinpatientswithsubclinicallymphedemadiagnosedinthepreoperativeperiodviabioimpedance
AT cansunakipoglu evaluationoflongtermlymphedemarateinpatientswithsubclinicallymphedemadiagnosedinthepreoperativeperiodviabioimpedance
AT enverozkurt evaluationoflongtermlymphedemarateinpatientswithsubclinicallymphedemadiagnosedinthepreoperativeperiodviabioimpedance
AT filizcelebi evaluationoflongtermlymphedemarateinpatientswithsubclinicallymphedemadiagnosedinthepreoperativeperiodviabioimpedance
AT caglarunal evaluationoflongtermlymphedemarateinpatientswithsubclinicallymphedemadiagnosedinthepreoperativeperiodviabioimpedance
AT alperozturk evaluationoflongtermlymphedemarateinpatientswithsubclinicallymphedemadiagnosedinthepreoperativeperiodviabioimpedance
AT gulalco evaluationoflongtermlymphedemarateinpatientswithsubclinicallymphedemadiagnosedinthepreoperativeperiodviabioimpedance
AT cetinordu evaluationoflongtermlymphedemarateinpatientswithsubclinicallymphedemadiagnosedinthepreoperativeperiodviabioimpedance
AT gurselsoybir evaluationoflongtermlymphedemarateinpatientswithsubclinicallymphedemadiagnosedinthepreoperativeperiodviabioimpedance